---
title: "Pharscin Pharma's controlling shareholders and executives plan to reduce their holdings by no more than 4.1803 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240024680.md"
description: "According to the Zhitong Finance APP, Pharscin Pharma announced that its controlling shareholder Chengdu Local Construction Machinery Engineering Co., Ltd. (referred to as \"Chengdu Dijiang\") and senior management member Peng Xiaoyan plan to reduce their holdings in the company by a total of no more than 4.1803 million shares"
datetime: "2025-05-13T12:51:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240024680.md)
  - [en](https://longbridge.com/en/news/240024680.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240024680.md)
generator: "portal-rs"
---

# Pharscin Pharma's controlling shareholders and executives plan to reduce their holdings by no more than 4.1803 million shares

According to the Zhitong Finance APP, Pharscin Pharma (002907.SZ) announced that its controlling shareholder Chengdu Local Construction Machinery Engineering Co., Ltd. (referred to as "Chengdu Dijiang") and senior management personnel Peng Xiaoyan plan to reduce their holdings in the company by a total of no more than 4.1803 million shares

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [FLU: Profit and EBITDA up on Malta growth and cost cuts, with 2026 guidance raised](https://longbridge.com/en/news/296306424.md)
- [Innventure directors force management, board to forfeit Accelsius earnout shares tied to DarkNX order](https://longbridge.com/en/news/296352522.md)
- [US Cocoa Futures (COCOA-F) Surges on Aug 19: Key Factors to Watch](https://longbridge.com/en/news/296344984.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**